Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Non-cash Items (2019 - 2024)

Historic Non-cash Items for Harvard Bioscience (HBIO) over the last 6 years, with Q3 2024 value amounting to $28000.0.

  • Harvard Bioscience's Non-cash Items changed N/A to $28000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $28000.0, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2023, which is 86631.58% up from last year.
  • Harvard Bioscience's Non-cash Items amounted to $28000.0 in Q3 2024.
  • Harvard Bioscience's 5-year Non-cash Items high stood at $5.6 million for Q4 2021, and its period low was $28000.0 during Q3 2024.
  • In the last 5 years, Harvard Bioscience's Non-cash Items had a median value of $964000.0 in 2024 and averaged $1.6 million.
  • Per our database at Business Quant, Harvard Bioscience's Non-cash Items surged by 87003.89% in 2020 and then tumbled by 9657.84% in 2022.
  • Harvard Bioscience's Non-cash Items (Quarter) stood at $2.5 million in 2020, then surged by 122.74% to $5.6 million in 2021, then plummeted by 96.58% to $190000.0 in 2022, then surged by 866.32% to $1.8 million in 2023, then plummeted by 98.47% to $28000.0 in 2024.
  • Its Non-cash Items stands at $28000.0 for Q3 2024, versus $91000.0 for Q2 2024 and $964000.0 for Q1 2024.